A phase I dose-finding, pharmacokinetics and genotyping study of olaparib and lurbinectedin in patients with advanced solid tumors.
Scientific Reports
Poveda, Andres A; Oaknin, Ana A; Romero, Ignacio I; Guerrero-Zotano, Angel A; FariƱas-Madrid, Lorena L; Rodriguez-Freixinos, Victor V; Mallol, Pedro P; Lopez-Reig, Raquel R; Lopez-Guerrero, Jose Antonio JA
False-negative errors in next-generation sequencing contribute substantially to inconsistency of mutation databases.
Plos One
Kim, Young-Ho YH; Song, Yura Y; Kim, Jong-Kwang JK; Kim, Tae-Min TM; Sim, Hye Won HW; Kim, Hyung-Lae HL; Jang, Hyonchol H; Kim, Young-Woo YW; Hong, Kyeong-Man KM